Autopsy report · NCT00453908
Alfuzosin Versus Placebo in Acute Urinary Retention
Cause of deathSlow enrollment
“The study was early terminated due to slow and difficult recruitment”
Life of this trial
- Registered 2 years 10 months after it had already started.
- 160 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Urinary Retention
- Interventions
- Alfuzosin
- Participants
- 160
- Sites
- 1
- Countries
- Denmark
Trials that died the same way
- Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab
“Study was terminated early because of slow recruitment” - THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
“Study terminated due to slow recruitment.” - Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
“Slow recruitment; Study was terminated for futility reasons” - A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System
“Study was terminated early due to prolonged recruitment period.” - To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
“the study was early terminated due to lack of recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.